Literature DB >> 20613703

Progress toward poliomyelitis eradication - Nigeria, January 2009-June 2010.

.   

Abstract

Nigeria has maintained a high incidence of wild poliovirus (WPV) cases attributed to persistently high proportions of under- and unimmunized children, and, for many years, the country has served as a reservoir for substantial international spread. In 2008, Nigeria reported 798 polio cases, the highest number of any country in the world. This report provides an update on poliovirus epidemiology in Nigeria during the past 18 months, January 2009-June 2010, and describes activities planned to interrupt transmission. Reported WPV cases in Nigeria decreased to 388 during 2009 (24% of global cases), and WPV incidence in Nigeria reached an all-time low during January--June 2010, with only three reported cases. Cases of circulating type 2 vaccine-derived poliovirus (cVDPV2), which first occurred in Nigeria in 2005, also declined, from 148 during the 12 months of 2009, to eight during the 6-month period, January-June 2010. One indicator of the effectiveness of immunization activities is the proportion of children with nonpolio acute flaccid paralysis (AFP) who never have received oral poliovirus vaccine (OPV). In seven high-incidence northern states of Nigeria, this proportion declined from 17.6% in 2008 to 10.7% in 2009. During 2009-2010, increased engagement of traditional, religious, and political leaders has improved community acceptance of vaccination and implementation of high-quality supplementary immunization activities (SIAs). Enhanced surveillance for polioviruses, further strengthened implementation of SIAs, and immediate immunization responses to newly identified WPV and cVDPV2 cases will be pivotal in interrupting WPV and cVDPV2 transmission in Nigeria.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20613703

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  9 in total

1.  Preeradication vaccine policy options for poliovirus infection and disease control.

Authors:  Kimberly M Thompson; Mark A Pallansch; Radboud J Duintjer Tebbens; Steve G Wassilak; Jong-Hoon Kim; Stephen L Cochi
Journal:  Risk Anal       Date:  2013-03-05       Impact factor: 4.000

2.  Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.

Authors:  Michael Famulare; Stewart Chang; Jane Iber; Kun Zhao; Johnson A Adeniji; David Bukbuk; Marycelin Baba; Matthew Behrend; Cara C Burns; M Steven Oberste
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

Review 3.  The role of research in viral disease eradication and elimination programs: lessons for malaria eradication.

Authors:  Joel G Breman; Ciro A de Quadros; Walter R Dowdle; William H Foege; Donald A Henderson; T Jacob John; Myron M Levine
Journal:  PLoS Med       Date:  2011-01-25       Impact factor: 11.069

4.  Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population.

Authors:  Steven Wassilak; Muhammad Ali Pate; Kathleen Wannemuehler; Julie Jenks; Cara Burns; Paul Chenoweth; Emmanuel Ade Abanida; Festus Adu; Marycelin Baba; Alex Gasasira; Jane Iber; Pascal Mkanda; A J Williams; Jing Shaw; Mark Pallansch; Olen Kew
Journal:  J Infect Dis       Date:  2011-04-01       Impact factor: 5.226

Review 5.  Recombination between poliovirus and coxsackie A viruses of species C: a model of viral genetic plasticity and emergence.

Authors:  Nicolas Combelas; Barbara Holmblat; Marie-Line Joffret; Florence Colbère-Garapin; Francis Delpeyroux
Journal:  Viruses       Date:  2011-08-17       Impact factor: 5.048

6.  Has Wild Poliovirus Been Eliminated from Nigeria?

Authors:  Michael Famulare
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

7.  COVID-19 Vaccine Hesitancy and Determinants of Acceptance among Healthcare Workers, Academics and Tertiary Students in Nigeria.

Authors:  Emmanuel O Njoga; Philip P Mshelbwala; Kenneth O Abah; Olajoju J Awoyomi; Kinley Wangdi; Shedrach B Pewan; Felix A Oyeleye; Haruna B Galadima; Salisu A Alhassan; Chinwe E Okoli; Elisha Z Kwaja; Onyinye S Onwumere-Idolor; Everest O Atadiose; Priscilla O Awoyomi; Musawa A Ibrahim; Kabiru M Lawan; Shehu A Zailani; Mohammed D Salihu; Charles E Rupprecht
Journal:  Vaccines (Basel)       Date:  2022-04-15

8.  Detection of immunoglobulin G levels produced by oral polio vaccine in HIV infected children in Jos, Plateau State, Nigeria.

Authors:  Fwangshak Ayuba Lengkat; Onuoha Stanley Chukwudozie; Oladele Olasoji Vincent; Dasun Martin James; Hashimu Godiya Amina; Onyedibe Kenneth
Journal:  Pan Afr Med J       Date:  2019-12-06

9.  Field investigation and response to a vaccine-derived poliovirus pre-tOPV switch in Southwest Nigeria, October 2015.

Authors:  Akinola Fatiregun; Ekundare Famiyesin; Samuel Bawa; Ninilola Ogunbodede
Journal:  Pan Afr Med J       Date:  2020-09-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.